New Era Energy & Digital (NASDAQ:NUAI) said it has closed an overallotment option on its public stock offering, bringing total gross proceeds to approximately $115 million, as the Permian Basin-focused digital infrastructure company works to fund development of a large Texas data center complex.
The company also received the first $20 million tranche of a $290 million senior secured term loan from Macquarie Group's Commodities and Global Markets division, alongside a separate $5 million equity investment from Macquarie at roughly $5 per share.
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) said on Tuesday it has appointed IJG Securities as sponsor and corporate adviser and begun discussions with the Namibia Securities Exchange as it seeks admission to trade on the country’s national exchange.
Following any successful listing, Sintana said it plans to explore options to develop liquidity for local Namibian investors and broaden domestic participation in its shareholding base.
374Water Inc (NASDAQ:SCWO, FRA:8LL) announced on Tuesday that it has reappointed Rick Davis, who previously served on its board from 2021 until June 2025, to its board of directors.
According to the company, Davis brings more than 30 years of experience in investment banking, corporate finance, and clean technology.
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) announced it has achieved cash flow positive operations following the completion of a company-wide optimization program driven by artificial intelligence.
The Toronto-based firm said the initiative focused on automating processes across product development, engineering, and go-to-market functions, alongside organizational restructuring aimed at reducing operational redundancy. As a result, the company expects to reach an annualized cost savings run rate of approximately $400,000 once remaining measures are finalized by May 1.
Trillion Energy International Inc. (CSE:TCF, OTCQB:TRLEF, FRA:Z620) said it has made a light oil discovery at its Çetinkaya-1 well in southeastern Türkiye and is shifting focus toward high-impact oil exploration, after drilling results confirmed multiple hydrocarbon-bearing zones.
Shares of Trillion surged 110% on the news.
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said on Tuesday an abstract from its mid-stage study of experimental Parkinson’s disease treatment bezisterim has been accepted for presentation at an upcoming neurology conference.
The abstract, based on the company’s SUNRISE-PD trial evaluating bezisterim in patients with early Parkinson’s disease, will be presented at the American Academy of Neurology Annual Meeting later this week.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said on Tuesday a late-breaking poster on its Phase 2a study of intranasal foralumab in Multiple System Atrophy (MSA) has been accepted for presentation at the World Parkinson Congress in Phoenix, Arizona in May 2026.
The poster, titled “A Phase 2a Study of Intranasal Foralumab in Multiple System Atrophy,” will outline the design and rationale of the ongoing TILS-025 trial, the company said.
Replenish Nutrients Holding Corp (CSE:ERTH, OTC:VVIVF, FRA:7KE) announced that it has been approved for up to $250,000 in funding under the Sustainable Canadian Agricultural Partnership (Sustainable CAP) Value-Added Program, which will be used to advance the company’s Beiseker, Alberta, facility.
The funding, provided jointly by the federal and Alberta governments, builds on capital investments made in 2025 to expand fertilizer processing capabilities at Beiseker.
Purepoint Uranium Group Inc (TSX-V:PTU, OTCQX:PTUUF, FRA:P5X0) said on Tuesday its winter 2026 drill program at the Dorado joint venture project in northern Saskatchewan successfully extended uranium mineralization at the Nova discovery, supporting the potential scale of the find.
The Vancouver-based explorer, which operates the project in a 50/50 partnership with IsoEnergy, completed nine drill holes totaling 5,210 metres within the Nova Zone in the Athabasca Basin, one of the world’s richest uranium regions.
A peer-reviewed pilot study at a Canadian critical care centre marks the first deployment of nasal photodisinfection in an intensive care setting.
Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) shares rose 8% to 11.85p after the company announced a peer-reviewed publication of a pilot study showing its Steriwave nasal photodisinfection therapy reduced pneumonia rates by 39.5% in intensive care unit patients.
Orosur Mining Inc (AIM:OMI, TSX-V:OMI) shares rose 19% to 21.1p after the company reported the discovery of a new gold mineralised zone 100 metres west of its Pepas deposit at the Anzá project in Colombia.
Drill hole PEP082 intersected 26.4 metres at 2.85 grams per tonne gold from 5.3 metres depth, while the follow-up hole PEP083 returned 14.45 metres at 8.27 grams per tonne from surface, including a high-grade interval of 2.55 metres at 42.7 grams per tonne.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has secured a significant expansion of the US commercial rollout for its flagship FebriDx test, with WellStreet Urgent Care agreeing to deploy the rapid point-of-care respiratory test across an additional 43 locations following a successful initial pilot.
The move marks a step-up from a single-site program and comes shortly after the test received CLIA waiver clearance from the US Food and Drug Administration, a key milestone that enables broader use in point-of-care settings.
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has secured $2.2 million through a fully subscribed entitlement offer, strengthening its balance sheet as it advances its lead cancer therapy towards a planned phase II trial.
The company confirmed the completion of its 2-for-5 non-renounceable entitlement offer, with strong backing from both existing shareholders and new investors helping to fill the book.
Connecting Excellence Group Plc (AQSE:XCE, OTCQB:XCELF), the international executive recruitment firm that holds Bitcoin as a core treasury asset, has received 0.516 Bitcoin worth approximately £27,472 as payment for executive recruitment services provided through its flagship business, Spencer Riley.
The company believes this marks the first time a UK-listed recruitment business has both invoiced and settled service fees in Bitcoin.
Nova Minerals Ltd (ASX:NVA, NASDAQ:NVA, OTC:NVAAF, FRA:QM3) has outlined a potentially significant new gold anomaly at its flagship Estelle Gold and Critical Minerals Project in Alaska, with early-stage surface sampling at Portage Pass pointing to similarities with the nearby multi-million-ounce Korbel deposit.
Results from the 2025 field season at the Portage Pass prospect, located about 2.5 kilometres south of Korbel, have identified a broad zone of gold mineralisation supported by both soil and rock assays.
Riversgold Ltd (ASX:RGL, FRA:RGV, OTC:RVSGF) has begun exploration activities at its Saint John gold-copper-antimony project in New Brunswick, Canada, with a high-resolution airborne geophysical survey set to begin this week.
The program is being executed by earn-in partner A.I.S. Resources and will involve a helicopter-borne magnetic survey covering 2,125 line kilometres at 50-metre spacing. Under the existing agreement, A.I.S. can earn up to 75% of the project by spending C$4.4 million over four years, with Riversgold retaining a 25% free-carried interest through to decision to mine.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has received a US$5 million milestone pre-payment from its US distribution partner Phase Scientific, with its FebriDx® point-of-care test now moving into broader commercial rollout across the United States.
The payment follows the recent US Food and Drug Administration 510(k) clearance and CLIA waiver for FebriDx®, which satisfies a major milestone under the companies’ distribution agreement.
Resolution Minerals Ltd (ASX:RML, OTCQB:RLMLF, FRA:NC3) has produced high-purity antimony trioxide from its Antimony Ridge deposit in Idaho, a key step forward in its metallurgical program and broader US-focused critical minerals strategy.
Conventional pyrometallurgical test work has successfully produced an intermediate antimony trioxide product grading 99.38% Sb₂O₃ from stibnite samples sourced from historical open pits.
Orthocell Ltd (ASX:OCC, OTC:ORHHF) will release its quarterly results for the period ended March 31, 2026, on Monday, April 20, and host an investor webinar the same day.
The webinar will cover its quarterly results and provide an operational update, including progress on the US rollout of Remplir and its use in prostate cancer surgeries in Australia.